These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35748297)

  • 1. Generation of functional human oligodendrocytes from dermal fibroblasts by direct lineage conversion.
    Tanabe K; Nobuta H; Yang N; Ang CE; Huie P; Jordan S; Oldham MC; Rowitch DH; Wernig M
    Development; 2022 Oct; 149(20):. PubMed ID: 35748297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.
    Elitt MS; Shick HE; Madhavan M; Allan KC; Clayton BLL; Weng C; Miller TE; Factor DC; Barbar L; Nawash BS; Nevin ZS; Lager AM; Li Y; Jin F; Adams DJ; Tesar PJ
    Stem Cell Reports; 2018 Sep; 11(3):711-726. PubMed ID: 30146490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation.
    Nobuta H; Yang N; Ng YH; Marro SG; Sabeur K; Chavali M; Stockley JH; Killilea DW; Walter PB; Zhao C; Huie P; Goldman SA; Kriegstein AR; Franklin RJM; Rowitch DH; Wernig M
    Cell Stem Cell; 2019 Oct; 25(4):531-541.e6. PubMed ID: 31585094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
    Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
    Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of oligodendroglial cells by direct lineage conversion.
    Yang N; Zuchero JB; Ahlenius H; Marro S; Ng YH; Vierbuchen T; Hawkins JS; Geissler R; Barres BA; Wernig M
    Nat Biotechnol; 2013 May; 31(5):434-9. PubMed ID: 23584610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
    Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
    Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a fluorescent oligodendrocyte reporter line in human induced pluripotent stem cells.
    Schreiber MK; Zafeiriou MP
    Stem Cell Res; 2024 Mar; 75():103295. PubMed ID: 38219302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-step Reprogramming of Human Fibroblasts into Oligodendrocyte-like Cells by SOX10, OLIG2, and NKX6.2.
    Chanoumidou K; Hernández-Rodríguez B; Windener F; Thomas C; Stehling M; Mozafari S; Albrecht S; Ottoboni L; Antel J; Kim KP; Velychko S; Cui QL; Xu YKT; Martino G; Winkler J; Schöler HR; Baron-Van Evercooren A; Boespflug-Tanguy O; Vaquerizas JM; Ehrlich M; Kuhlmann T
    Stem Cell Reports; 2021 Apr; 16(4):771-783. PubMed ID: 33770499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor cell memory confers a metastable state of directly converted cells.
    Kim KP; Li C; Bunina D; Jeong HW; Ghelman J; Yoon J; Shin B; Park H; Han DW; Zaugg JB; Kim J; Kuhlmann T; Adams RH; Noh KM; Goldman SA; Schöler HR
    Cell Stem Cell; 2021 Jul; 28(7):1291-1306.e10. PubMed ID: 33848472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal and partial inhibition of GLI1 in neural stem cells (NSCs) results in the early maturation of NSC derived oligodendrocytes in vitro.
    Namchaiw P; Wen H; Mayrhofer F; Chechneva O; Biswas S; Deng W
    Stem Cell Res Ther; 2019 Aug; 10(1):272. PubMed ID: 31455382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.
    Najm FJ; Lager AM; Zaremba A; Wyatt K; Caprariello AV; Factor DC; Karl RT; Maeda T; Miller RH; Tesar PJ
    Nat Biotechnol; 2013 May; 31(5):426-33. PubMed ID: 23584611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
    Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
    Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells.
    Yamashita T; Miyamoto Y; Bando Y; Ono T; Kobayashi S; Doi A; Araki T; Kato Y; Shirakawa T; Suzuki Y; Yamauchi J; Yoshida S; Sato N
    PLoS One; 2017; 12(2):e0171947. PubMed ID: 28192470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Lineage Transcription Factors Identifies Differences in Transition States of Induced Human Oligodendrocyte Differentiation.
    Raabe FJ; Stephan M; Waldeck JB; Huber V; Demetriou D; Kannaiyan N; Galinski S; Glaser LV; Wehr MC; Ziller MJ; Schmitt A; Falkai P; Rossner MJ
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of the human induced pluripotent stem cell line (ZJUi005-A) from a patient with Pelizaeus-Merzbacher disease (PMD) carrying a novel hemizygous mutation in PLP1 gene.
    Liu B; Chen L; Sun J; Zhang L; Chen M; Qian Y; Wang Y; Yan K; Hou L; Huang Y; Zhang D; Xu Y; Yu J; Zhang J; Dong M
    Stem Cell Res; 2020 May; 45():101791. PubMed ID: 32402715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease.
    Gruenenfelder FI; McLaughlin M; Griffiths IR; Garbern J; Thomson G; Kuzman P; Barrie JA; McCulloch ML; Penderis J; Stassart R; Nave KA; Edgar JM
    Brain; 2020 May; 143(5):1383-1399. PubMed ID: 32419025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.
    Miyamoto Y; Torii T; Tanoue A; Yamauchi J
    Biochem Biophys Res Commun; 2012 Jul; 424(2):262-8. PubMed ID: 22750001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.
    Osorio MJ; Rowitch DH; Tesar P; Wernig M; Windrem MS; Goldman SA
    Stem Cells; 2017 Feb; 35(2):311-315. PubMed ID: 27882623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA.
    Li H; Okada H; Suzuki S; Sakai K; Izumi H; Matsushima Y; Ichinohe N; Goto YI; Okada T; Inoue K
    JCI Insight; 2019 May; 4(10):. PubMed ID: 31092737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of oligodendrocytes from adult human olfactory epithelial-derived progenitors by transcription factors.
    Zhang X; Cai J; Klueber KM; Guo Z; Lu C; Qiu M; Roisen FJ
    Stem Cells; 2005 Mar; 23(3):442-53. PubMed ID: 15749939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.